Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 11;20(1):1097.
doi: 10.1186/s12885-020-07611-9.

Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis

Affiliations

Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis

Juliana Alexandra Hernández Vargas et al. BMC Cancer. .

Abstract

Background: Cancer is widely recognized as a global public health problem. Breast, prostate, and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical, and prostate cancer across regions and municipalities in Colombia during 2018.

Methods: We performed a cross-sectional analysis with data from people with breast, prostate, or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional, and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations.

Results: Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates per 100,000 were: 18.69 (CI 95%: 18.15-19.25) and 10.48 (CI 95%: 10.07-10.91); 11.34 (CI 95%: 10.90-11.78) and 7.58 (CI 95%: 7.22-7.96); 5.93 (CI 95%: 5.62-6.25) and 4.31 (CI 95%: 4.05-4.58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there was a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types.

Conclusions: We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection, and treatment in the country.

Keywords: Cancer; Epidemiology; Incidence; Mortality; Registries.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Age-standardized incidence rates of breast, prostate and cervical cancer by municipalities, Colombia 2018. Figure 1 shows the age-standardized incidence rates for each cancer by municipalities (a) Age-standardized incidence rates of breast cancer (b) Age-standardized incidence rates of prostate cancer (c) Age-standardized incidence rates of cervical cancer. ASR: Age-Standardized Rates. Data source: new cases of cancer reported to the National Administrative Cancer Registry during 2018
Fig. 2
Fig. 2
Age-standardized mortality rates of breast, prostate and cervical cancer by municipalities, Colombia 2018. Figure 2 shows the age-standardized mortality rates for each cancer by municipalities (a) Age-standardized mortality rates of breast cancer (b) Age-standardized mortality rates of prostate cancer (c) Age-standardized mortality rates of cervical cancer. ASR: Age-Standardized Rates. Data source: cancer deaths reported to the National Administrative Cancer Registry during 2018

Comment in

References

    1. Hoebel J, Kroll LE, Fiebig J, Lampert T, Katalinic A, Barnes B, et al. Socioeconomic inequalities in Total and site-specific Cancer incidence in Germany: a population-based registry study. Front Oncol. 2018;8(September):1–13. - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768. doi: 10.1001/jamaoncol.2019.2996. - DOI - PMC - PubMed
    1. World Health Organization . World cancer report: cancer research for cancer prevention. Lyon: International Agency for Research on Cancer; 2020. p. 630.
    1. Bray F, Piñeros M. Cancer patterns, trends and projections in latin america and the caribbean: a global context. Salud Publica Mex. 2016;58(2):104–117. doi: 10.21149/spm.v58i2.7779. - DOI - PubMed

MeSH terms